Alzheimer’s disease and related dementias are devastating conditions for a person and their family and caregivers. The progressive course of dementia can threaten an individual’s autonomy, and families can be emotionally, physically, mentally, and financially strained. Often, a
Guiding an Improved Dementia Experience by Clearing the Path for Comprehensive, High-Quality Dementia Care
Quality
Listing of blog posts tagged with Quality
- Blog
CMS Launches Action Plan for Sickle Cell Disease Month
Everyone deserves a fair and just opportunity to attain their optimal health and well-being. For far too long, this ideal has felt out of reach for many individuals living with Sickle Cell Disease (SCD). Sickle Cell Disease – an inherited blood disorder, affects approximately 100,000 individuals in the United States, the majority of whom are Black/African American, and/or Hispanic. Too often, individuals with SCD experience pain crises, need hospitalization, navigate complicated care transitions, and face stigma and discrimination in the healthcare system. As we reflect on Sickle Cell Read more about CMS Launches Action Plan for Sickle Cell Disease Month - Blog
Organ Transplantation Affinity Group (OTAG): Strengthening accountability, equity, and performance
Improving the organ transplantation system is a priority for the Biden-Harris Administration. In 2021, the Department of Health and Human Services Secretary Becerra established a coordinated effort to improve organ donation, procurement, and transplantation. Led by the Centers for Medicare & Medicaid Services (CMS) and the Health Resources and Services Administration (HRSA), this collaborative seeks to drive improvements in donations, clinical outcomes, system improvement, quality measurement, transparency, and regulatory oversight. The organ transplantation system consists of: A national body Read more about Organ Transplantation Affinity Group (OTAG): Strengthening accountability, equity, and performance - Blog
The Transplant Eco-System: The Role of Data in CMS Oversight of The Organ Procurement Organizations
The Centers for Medicare & Medicaid Services (CMS) and the Health Resources and Services Administration (HRSA) are federal agencies within the U.S. Department of Health and Human Services (HHS) that play important roles in protecting the health and safety of Americans as they engage with the U.S. healthcare system. The agencies share responsibility for overseeing the organ donation, procurement, and transplantation system. T his is accomplished through CMS’ oversight of the Organ Procurement Organizations (OPOs) and transplant programs, along with HRSA’s oversight of the Organ Procurement and Read more about The Transplant Eco-System: The Role of Data in CMS Oversight of The Organ Procurement Organizations - Blog
The Path Forward: Improving Data to Advance Health Equity Solutions
A True Focus on Data to Advance Health Equity The Centers for Medicare & Medicaid Services Office of Minority Health has released “The Path Forward: Improving Data to Advance Health Equity Solutions”, which for the first time, outlines a plan to tackle health equity data efforts across CMS programs to achieve health equity by underlining the importance of health equity data collection and chart the next steps for CMS to improve data collection efforts and, in turn, advance health equity. As we look back over the last few years and reorient our perspective to the future of health care in the Read more about The Path Forward: Improving Data to Advance Health Equity Solutions - Blog
The CMS National Quality Strategy: A Person-Centered Approach to Improving Quality
The Centers for Medicare & Medicaid Services (CMS) administers health care coverage for more than 150 million individuals through Medicare, Medicaid, the Children’s Health Insurance Program (CHIP), and the Marketplace – HealthCare.gov. The vision of the agency is straightforward: To serve the public as a trusted partner and steward, dedicated to advancing health equity, expanding access to affordable coverage and care, and improving health outcomes – the latter being key to this discussion. In addition to its traditional role in coverage, CMS has a critically important responsibility for Read more about The CMS National Quality Strategy: A Person-Centered Approach to Improving Quality - Blog
Medicare Coverage of Innovative Technologies (MCIT)
The Centers for Medicare & Medicaid Services (CMS) is committed to ensuring people on Medicare have quicker access to innovative medical technologies for life-threatening or irreversibly debilitating diseases – like cancer and heart disease. In January 2021, we published a final rule called The Medicare Coverage of Innovative Technology and Definition of ‘Reasonable and Necessary’ (MCIT/R&N). The rule would have granted expedited Medicare coverage for up to four years for any U.S. Food & Drug Administration (FDA)-designated breakthrough device once the device received or cleared market Read more about Medicare Coverage of Innovative Technologies (MCIT)